Results 261 to 270 of about 3,189,219 (271)

Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom

Current Medical Research and Opinion, 2008
R Akehurst, K Tolley, J Karnon
exaly  

Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry

Leukemia Research, 2012
Kathrin Nachtkamp, Judith Neukirchen, Rainer Haas   +2 more
exaly  

Iron Chelating Macromolecules for Intravascular Iron Chelation Therapy

2010
Nicholas A. A. Rossi, Jayachandran N. Kizhakkedathu   +1 more
openaire   +1 more source

High Rate of Erythroid Response During Iron Chelation Therapy in a Cohort of 105 Patients Affected by Hematologic Malignancies with Transfusional Iron Overload: An Italian Multicenter Retrospective Study

Blood, 2011
Alessandro Levis, Bernardino Allione, Emanuela Messa   +2 more
exaly  

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia

International Journal of Molecular Sciences, 2017
Ali Taher, Maria Domenica Cappellini, Bachar F Chaya   +2 more
exaly  

Insights into Relationships Between Serum Ferritin and Liver Iron Concentration Trends during 12 Months of Iron Chelation Therapy with Deferasirox – a Post-Hoc Analysis from the Epic Study

Blood, 2014
Yesim Aydınok, Ali Taher, Mohsen Elalfy
exaly  

Iron chelators in tumor therapy

2019
HOPPE-SEYLER FELIX, BRAUN JULIA A, HOPPE-SEYLER KARIN   +2 more
openaire   +3 more sources

Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results

Hematology, 2009
Isabelle Thuret
exaly  

Iron Chelation Therapy

2002
openaire   +1 more source

Iron chelating therapy.

Bailliere's clinical haematology, 1989
openaire   +1 more source